To hear about similar clinical trials, please enter your email below

Trial Title: IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

NCT ID: NCT05987332

Condition: Metastatic Uveal Melanoma

Conditions: Official terms:
Melanoma
Uveal Neoplasms
Pembrolizumab
Nivolumab
Ipilimumab
Dacarbazine
Crizotinib

Conditions: Keywords:
IDE196
Darovasertib
Protein Kinase C
Metastatic Uveal Melanoma
Melanoma
Ocular Oncology
Ophthalmology
Crizotinib
Ocular melanoma

Study type: Interventional

Study phase: Phase 2/Phase 3

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Sequential Assignment

Primary purpose: Treatment

Masking: None (Open Label)

Intervention:

Intervention type: Drug
Intervention name: IDE196
Description: Dosed orally, twice daily
Arm group label: Phase 2a Dose Optimization of IDE196 + crizotinib
Arm group label: Phase 2b / 3 Chosen Combination dose of IDE196 + crizotinib

Other name: Darovasertib

Intervention type: Drug
Intervention name: Crizotinib
Description: Dosed orally, twice daily
Arm group label: Phase 2a Dose Optimization of IDE196 + crizotinib
Arm group label: Phase 2b / 3 Chosen Combination dose of IDE196 + crizotinib

Other name: XALKORI

Intervention type: Drug
Intervention name: Pembrolizumab
Description: IV administration every 3 weeks
Arm group label: Phase 2a / 2b / 3 Comparator Arm

Other name: Keytruda

Intervention type: Drug
Intervention name: Ipilimumab
Description: IV administration every 3 weeks for 4 Cycles
Arm group label: Phase 2a / 2b / 3 Comparator Arm

Other name: Yervoy

Intervention type: Drug
Intervention name: Nivolumab
Description: IV administration every 3 Weeks for 4 Cycles, thereafter every 4 Weeks maintenance
Arm group label: Phase 2a / 2b / 3 Comparator Arm

Other name: Opdivo

Intervention type: Drug
Intervention name: Dacarbazine
Description: IV administration every 3 Weeks
Arm group label: Phase 2a / 2b / 3 Comparator Arm

Other name: DTIC-Dome

Summary: This is a Phase 2/3, multi-arm, multi-stage, open-label study of human leukocyte antigen (HLA)-A*02:01 negative participants with metastatic uveal melanoma (MUM) who will be randomized to receive either IDE196 + crizotinib or investigator's choice of treatment (pembrolizumab, ipilimumab + nivolumab, or dacarbazine).

Detailed description: This study is designed as a multi-stage Phase 2 study within a Phase 3 study to evaluate the safety, tolerability, pharmacokinetics, dose-exposure relationship, and anti-tumor activity of IDE196 in combination with crizotinib compared to the comparator arm of investigator's choice of treatment (pembrolizumab, ipilimumab + nivolumab, or dacarbazine). The Phase 2a dose optimization stage will evaluate two doses of IDE196 in combination with crizotinib compared to the comparator arm. Participants will be randomized to the three treatment arms. At the point of optimal IDE196 + crizotinib dose selection, the other dose arm will be dropped with discontinuation of enrollment to that arm. Participants receiving the IDE196 dose (in combination with crizotinib) that is not selected, will be offered the choice to remain on the same dose or change to the chosen optimal dose. The optimal dose will be chosen to complete the Phase 2b portion. The Phase 2b part of the study will continue to enroll the chosen combination dose of IDE196 + crizotinib compared with the comparator arm. Participants will be randomized to the two treatment arms. The Phase 3 part of the study will continue to enroll the chosen combination dose of IDE196 + crizotinib compared with the comparator arm. Participants will be randomized to the two treatment arms.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Histological or cytological confirmed Metastatic Uveal Melanoma - HLA-A*02:01 negative - No prior systemic therapy in the metastatic or advanced setting or regional or liver-directed therapy. Ablations or surgical resection of oligometastatic disease, and neoadjuvant or adjuvant therapy is allowed - Measurable disease per RECIST 1.1 - Able to be safely administered and absorb study therapy - ECOG performance status 0 or 1 - Life expectancy of ≥3 months - Adequate organ function Exclusion Criteria: - Previous treatment with a PKC inhibitor (including prior treatment with IDE196), an inhibitor directly targeting MET, or an inhibitor directly targeting GNAQ/11 - Concurrent malignant disease - AEs from prior anti-cancer therapy that have not resolved to Grade ≤1 - Symptomatic or untreated central nervous system (CNS) metastases, or CNS metastases that require corticosteroids - High risk of syncope - Known AIDS related illness or active Hep B/C - Active adrenal insufficiency, active colitis, or active inflammatory bowel disease - History of interstitial lung disease, active pneumonitis, or history of pneumonitis - Active infection requiring systemic antibiotic therapy - Use of hematopoietic colony-stimulating factors (CSF) prior to start of study drug - Females who are pregnant or breastfeeding - History of severe hypersensitivity reactions (eg, anaphylaxis) to other biologic drugs or monoclonal antibodies - Contraindication for treatment with investigator's choice therapies as per applicable labelling - History of stroke within the last 6 months of the first dose of study drug - Has any other condition that may increase the risk associated with study participation or may interfere with the interpretation of study results and, in the opinion of the investigator, would make the participant inappropriate for entry into the study, including institutionalization on the basis of an official or court order

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Honor Health

Address:
City: Scottsdale
Zip: 85258
Country: United States

Status: Recruiting

Contact:
Last name: Oncology Clinical Trials Nurse Navigator

Phone: 480-323-1791
Email: clinicaltrials@honorhealth.com

Contact backup:

Phone: 833-354-6667

Facility:
Name: Moores Cancer Center

Address:
City: La Jolla
Zip: 92093
Country: United States

Status: Recruiting

Contact:
Last name: Katie O'Neil, BA

Phone: 858-822-5354
Email: croneil@health.ucsd.edu

Contact backup:
Last name: Jazelle Molina

Phone: 858-822-5354
Email: jgmolina@health.ucsd.edu

Facility:
Name: UCLA Medical Center

Address:
City: Los Angeles
Zip: 90024
Country: United States

Status: Recruiting

Contact:
Last name: Adyel Annelus

Phone: 310-794-4955
Email: aannelus@mednet.ucla.edu

Contact backup:
Last name: Elizabeth Seja

Phone: 310-794-6892
Email: eseja@mednet.ucla.edu

Facility:
Name: The Angeles Clinic and Research Institute

Address:
City: Los Angeles
Zip: 90025
Country: United States

Status: Recruiting

Contact:
Last name: Saba Mukarram

Phone: 310-231-2181
Email: smukarram@theangelesclinic.org

Facility:
Name: California Pacific Medical Center (CPMC)

Address:
City: San Francisco
Zip: 94115
Country: United States

Status: Recruiting

Contact:
Last name: Denise Fortun

Phone: 415-600-1775
Email: denise.fortun@sutterhealth.org

Contact backup:
Last name: CPMC Clinical Research Group
Email: clinicalresearch@sutterhealth.org

Facility:
Name: University of California San Francisco

Address:
City: San Francisco
Zip: 94143
Country: United States

Status: Recruiting

Contact:
Last name: Sonia Contreras Martinez, BSN

Phone: 415-514-6427
Email: sonia.contrerasmartinez@ucsf.edu

Facility:
Name: University of Colorado Cancer Center

Address:
City: Aurora
Zip: 80045
Country: United States

Status: Recruiting

Contact:
Last name: Sarah Mayer, BA

Phone: 303-724-5056
Email: sara.j.mayer@cuanschutz.edu

Contact backup:
Last name: Victoria Mayer, VA

Phone: 303-724-9807
Email: victoria.nuanes@cuanschutz.edu

Facility:
Name: SCRI at HealthONE

Address:
City: Denver
Zip: 80218
Country: United States

Status: Recruiting

Contact:
Last name: SCRI Front Desk

Phone: 720-754-2610
Email: cann.ddudenvergeneral@sarahcannon.com

Facility:
Name: University of Miami Sylvester Comprehensive Cancer Center

Address:
City: Miami
Zip: 33136
Country: United States

Status: Recruiting

Contact:
Email: CRSCutaneous@miami.edu

Facility:
Name: Moffitt Cancer Center

Address:
City: Tampa
Zip: 33612
Country: United States

Status: Recruiting

Contact:
Last name: Nikhil Khushalani, MD

Phone: 813-745-3437
Email: Nikhil.khushalani@moffitt.org

Contact backup:
Last name: Leticia Tetteh, BSN

Phone: 813-745-4617
Email: Leticia.tetteh@moffitt.org

Facility:
Name: Northside Hospital Atlanta

Address:
City: Atlanta
Zip: 30342
Country: United States

Status: Recruiting

Contact:
Last name: Central Research Department

Phone: 404-303-3355
Email: clinicaltrials@northside.com

Facility:
Name: University of Iowa

Address:
City: Iowa City
Zip: 52242
Country: United States

Status: Recruiting

Contact:
Last name: Asad Javed, MD

Phone: 319-467-5156
Email: asad-javed@uiowa.edu

Facility:
Name: Massachusetts General Hospital

Address:
City: Boston
Zip: 02114
Country: United States

Status: Recruiting

Contact:
Last name: Kamaneh Montazeri, MD

Phone: 617-724-4000
Email: kmontazeri@mgh.harvard.edu

Contact backup:
Last name: Ryan Sullivan, MD

Phone: 6177245197
Email: rsullivan7@mgh.harvard.edu

Facility:
Name: Dana Farber Cancer Institute

Address:
City: Boston
Zip: 02215
Country: United States

Status: Recruiting

Contact:
Last name: Rizwan Haq

Phone: 617-632-6168
Email: rizwan_haq@dfci.harvard.edu

Contact backup:
Last name: Linnea Drew

Phone: 617-632-6705
Email: linneam_drew@dfci.harvard.edu

Facility:
Name: The Cancer and Hematology Centers

Address:
City: Grand Rapids
Zip: 49546
Country: United States

Status: Recruiting

Contact:
Last name: The Cancer and Hematology Centers

Phone: 616-954-5550
Email: ClinicalTrials@chcwm.com

Contact backup:
Last name: Jessica Miller, RN

Phone: 616-954-5550

Phone ext: 1651
Email: Jmiller@chcwm.com

Facility:
Name: Minnesota Oncology Hematology, P.A.

Address:
City: Burnsville
Zip: 55337
Country: United States

Status: Recruiting

Contact:
Last name: Kayla McDonald
Email: kayla.mcdonald1@usoncology.com

Facility:
Name: Mayo Clinic

Address:
City: Rochester
Zip: 55905
Country: United States

Status: Recruiting

Contact:
Last name: Referral Office

Phone: 855-776-0015
Email: mayocliniccancerstudies@mayo.edu

Facility:
Name: Washington University School of Medicine

Address:
City: Saint Louis
Zip: 63110
Country: United States

Status: Recruiting

Contact:
Last name: Amer Alyasiry, MHS

Phone: 314-600-4605
Email: aalyasiry@wustl.edu

Contact backup:
Last name: Tyler Klein

Phone: 314-273-3072
Email: kleint@wustl.edu

Facility:
Name: Roswell Park Cancer Institute

Address:
City: Buffalo
Zip: 14263
Country: United States

Status: Recruiting

Contact:
Last name: Benjamin Switzer, DO

Phone: 716-845-7668
Email: benjamin.switzer@rosewellpark.org

Contact backup:
Last name: igor Puzanov, MD

Phone: 716-845-7505
Email: igor.puzanov@roswellpark.org

Facility:
Name: Northwell Health

Address:
City: Manhasset
Zip: 11030
Country: United States

Status: Recruiting

Contact:
Last name: Shaheer Khan, MD
Email: skhan137@northwell.edu

Contact backup:
Last name: Tracy Green, BS
Email: tgreen22@northwell.edu

Facility:
Name: Memorial Sloan Kettering Cancer Center

Address:
City: New York
Zip: 10065
Country: United States

Status: Recruiting

Contact:
Last name: Alexander Shoushtari, MD

Phone: 646-888-4161
Email: shoushta@mskcc.org

Contact backup:
Last name: James Smithy, MD

Phone: 929-623-0275
Email: smithyj@mskcc.org

Facility:
Name: Duke University Health System

Address:
City: Durham
Zip: 27710
Country: United States

Status: Recruiting

Contact:
Last name: Carol Ann Wiggs, BSN

Phone: 919-684-0281
Email: carolann.wiggs@duke.edu

Contact backup:
Last name: Emily Bolch

Phone: 919-668-6359
Email: emily.bolch@duke.edu

Facility:
Name: University of Cincinnati

Address:
City: Cincinnati
Zip: 45267
Country: United States

Status: Recruiting

Contact:

Phone: 513-584-7698
Email: cancer@uchealth.com

Facility:
Name: The Cleveland Clinic Foundation

Address:
City: Cleveland
Zip: 44195
Country: United States

Status: Recruiting

Contact:
Last name: Lucy Kennedy, MD

Phone: 216-444-7923
Email: KENNEDL5@ccf.org

Facility:
Name: Thomas Jefferson University

Address:
City: Philadelphia
Zip: 19107
Country: United States

Status: Recruiting

Contact:
Last name: Marlana Orloff

Phone: 215-955-9980
Email: Marlana.Orloff@Jefferson.edu

Contact backup:
Last name: Kristie Hensel

Phone: 215-955-9980
Email: Kristie.Hensel@Jefferson.edu

Facility:
Name: University of Pittsburgh Medical Center

Address:
City: Pittsburgh
Zip: 15232
Country: United States

Status: Not yet recruiting

Contact:
Last name: Amy Rose, RN,BSN

Phone: 412-647-8587
Email: kennaj@upmc.edu

Contact backup:
Last name: Jennifer Cleric, ND, RN

Phone: 412-864-7893
Email: clericja@upmc.edu

Facility:
Name: SCRI Oncology Partners

Address:
City: Nashville
Zip: 37203
Country: United States

Status: Recruiting

Contact:
Last name: SCRI Oncology Partners

Phone: 844-482-4812

Facility:
Name: Texas Oncology- DFW

Address:
City: Dallas
Zip: 75246
Country: United States

Status: Recruiting

Contact:
Last name: Christine Terraciano

Phone: 214-370-1942
Email: christine.terraciano@usoncology.com

Facility:
Name: UT Southwestern Medical Center

Address:
City: Dallas
Zip: 75390
Country: United States

Status: Recruiting

Contact:
Last name: Sanjay Chandrasekaran, MD

Phone: 833-722-6237
Email: sanjay.chandrasekaran@utsouthwestern.edu

Contact backup:
Last name: Desiree Pierre, BS

Phone: 214-648-3111
Email: desiree.pierre@utsouthwestern.edu

Facility:
Name: Houston Methodist Cancer Center

Address:
City: Houston
Zip: 77030
Country: United States

Status: Recruiting

Contact:
Last name: Anaum Maqsood

Phone: 713-441-9948
Email: amaqsood@houstonmethodist.org

Facility:
Name: MD Anderson Cancer Center

Address:
City: Houston
Zip: 77030
Country: United States

Status: Recruiting

Contact:
Last name: Alexandra Ikeguchi
Email: apikeguchi@mdanderson.org

Facility:
Name: Westmead Hospital

Address:
City: Sydney
Zip: 2145
Country: Australia

Status: Recruiting

Contact:
Last name: Matteo Carlino, MD

Phone: +61 288 905 200
Email: matteo.carlino@sydney.edu.au

Facility:
Name: Princess Alexander Hospital

Address:
City: Brisbane
Zip: 4102
Country: Australia

Status: Recruiting

Contact:
Last name: Janine Thomas

Phone: +61(0)731767578
Email: janine.thomas@health.qld.gov.au

Facility:
Name: Peter MacCallum Cancer Centre

Address:
City: Melbourne
Zip: 3000
Country: Australia

Status: Recruiting

Contact:
Last name: Damien Kee, MD
Email: damien.kee@petermac.org

Facility:
Name: Alfred Health

Address:
City: Melbourne
Zip: 3168
Country: Australia

Status: Recruiting

Facility:
Name: Sir Charles Gairdner Hospital

Address:
City: Perth
Zip: 6009
Country: Australia

Status: Recruiting

Contact:
Last name: Joanne Tonkin

Phone: 0863833185
Email: SCGH.MedOncCTM@health.wa.gov.au

Contact backup:
Last name: Rose McDowell

Phone: 0863833190
Email: Rose.McDowell@health.wa.gov.au

Facility:
Name: Queen Elizabeth Hospital

Address:
City: Adelaide
Country: Australia

Status: Recruiting

Contact:
Last name: Roberts-Thomson, MD

Facility:
Name: Cliniques Universitaires Saint Luc

Address:
City: Brussels
Zip: 1200
Country: Belgium

Status: Not yet recruiting

Contact:
Last name: Jean Francois Baurain, MD
Email: jean-francois.baurain@saintluc.uclouvain.be

Facility:
Name: Cross Cancer Institute, University of Alberta

Address:
City: Edmonton
Zip: T6G 1Z2
Country: Canada

Status: Not yet recruiting

Contact:
Last name: John Walker, MD,PhD,FRCPC

Phone: 780-577-8082
Email: john.walker2@ahs.ca

Facility:
Name: Princess Margaret Cancer Centre

Address:
City: Toronto
Zip: M5G 2M9
Country: Canada

Status: Recruiting

Contact:
Last name: Melissa Dalva

Phone: 416-946-4501

Phone ext: 5485
Email: Melissa.dalva@uhn.ca

Facility:
Name: Centre Hospitalier de l'Universite de Montreal- CHUM

Address:
City: Montréal
Zip: H2X 0C1
Country: Canada

Status: Recruiting

Contact:
Last name: Rahima Jamal, MD

Phone: 514-890-8444
Email: rahima.jamal.med@ssss.gouv.qc.ca

Contact backup:
Last name: Chantal Gosselin

Phone: 514-890-8000

Phone ext: 24892
Email: urcoh.eligibilite.chum@ssss.gouv.qc.ca

Facility:
Name: The Leon Berard Center

Address:
City: Lyon
Country: France

Status: Recruiting

Contact:
Last name: Eve-Marie Neidhardt, MD
Email: evemarie.neidhardt@lyon.unicancer.fr

Facility:
Name: Institut Curie

Address:
City: Paris
Zip: 75005
Country: France

Status: Recruiting

Contact:
Last name: Sophie Piperno-Neumann, MD

Phone: +33 0 1 44 32 40 68
Email: sophie.piperno-neumann@curie.fr

Facility:
Name: NCT Heidelberg

Address:
City: Heidelberg
Zip: 69120
Country: Germany

Status: Not yet recruiting

Contact:
Last name: Jessica Hassel, Prof. Dr. med
Email: Studien-DermaOnko.NCT@med.uni-heidelberg.de

Facility:
Name: Universitätsklinikum Essen (AöR)

Address:
City: Essen
Zip: 45147
Country: Germany

Status: Not yet recruiting

Contact:
Last name: Halime Kalkavan, Dr. med

Phone: +49 201 72384150
Email: halime.kalkavan@uk-essen.de

Facility:
Name: Universitätsklinikum Köln

Address:
City: Köln
Zip: 50937
Country: Germany

Status: Not yet recruiting

Contact:
Last name: Nicole Kreuzberg, MD
Email: halime.kalkavan@uk-essen.de

Facility:
Name: Universitätsklinikum Carl Gustav Carus Dresden

Address:
City: Dresden
Zip: 1307
Country: Germany

Status: Not yet recruiting

Contact:
Last name: Friedegund Meier, Prof. Dr. med

Phone: +49 (0) 351 458 19782
Email: oncostudien.dermatologie@ukdd.de

Facility:
Name: Charité - Universitätsmedizin Berlin

Address:
City: Berlin
Zip: 12203
Country: Germany

Status: Not yet recruiting

Contact:
Last name: Caroline Anna Peuker, MD

Phone: +49 30 450 513470
Email: caroline-anna.peuker@charite.de

Facility:
Name: Hadassah Medical Center

Address:
City: Jerusalem
Zip: 91120
Country: Israel

Status: Recruiting

Contact:
Last name: Jonathan Cohen, MD

Phone: 972 50 5172537
Email: cohenjon@hadassah.org.il

Contact backup:
Last name: Annaelle Dynovisz, SC

Phone: 972-58-4820222
Email: annaelled@hadassah.org.il

Facility:
Name: Sheba Medical Center

Address:
City: Ramat-Gan
Zip: 52621
Country: Israel

Status: Recruiting

Contact:
Last name: Ronnie Shapira, MD

Phone: 972 3-5302243
Email: ronnie.shapira@sheba.health.gov.il

Facility:
Name: Fondazione IRCCS Istituto Nazionale dei Tumori

Address:
City: Milano
Zip: 20133
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Lorenza DiGuardo, MD

Phone: 0039 02 23905000
Email: Lorenza.DiGuardo@istitutotumori.mi.it

Facility:
Name: Istituto Nazionale dei Tumori Fondazione Pascale

Address:
City: Napoli
Zip: 80131
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Paolo Ascierto, MD

Phone: +39 081 17770810
Email: melanoma.immunoterapia@istitutotumori.na.it

Facility:
Name: Fondazione Policlinico Gemelli IRCCS

Address:
City: Roma
Zip: 00168
Country: Italy

Status: Recruiting

Contact:
Last name: Ernesto Rossi, MD

Phone: +39 06 30156318
Email: ernesto.rossi@policlinicogemelli.it

Facility:
Name: AOUS Policlinico Le Scotte

Address:
City: Siena
Zip: 53100
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Michele Maio, MD

Phone: +39 0577586304
Email: dh.immunonco@ao-siena.toscana.it

Facility:
Name: LUMC (Leids Universitair Medisch Centrum)

Address:
City: Leiden
Zip: 2333 ZA
Country: Netherlands

Status: Not yet recruiting

Contact:
Last name: Ellen Kapiteijn, MD

Phone: +31 (0)71 526 1093
Email: h.w.kapiteijn@lumc.nl

Facility:
Name: Ośrodek Badań Klinicznych Wczesnych Faz, Uniwersyteckie Centrum Kliniczne w Gdańsku

Address:
City: Gdańsk
Zip: 80-214
Country: Poland

Status: Not yet recruiting

Contact:

Phone: +48 58 584 44 66
Email: obkwf@uck.gda.pl

Facility:
Name: Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy

Address:
City: Warsaw
Zip: 02-781
Country: Poland

Status: Not yet recruiting

Contact:

Phone: +48 22 546 21 03
Email: badaniakliniczne@pib-nio.pl

Facility:
Name: Catalan Institute of Oncology

Address:
City: L'Hospitalet de Llobregat
Zip: 8908
Country: Spain

Status: Not yet recruiting

Contact:
Last name: Josep Maria Piulats, MD

Phone: +34 932607744
Email: contactfortrialsICOLH@iconcologia.net

Facility:
Name: Hospital Universitario La Paz

Address:
City: Madrid
Zip: 28046
Country: Spain

Status: Not yet recruiting

Contact:
Last name: Yolanda Alvarez, BSc
Email: yolandalapaz@gmail.com

Facility:
Name: Hospital Clínico Universitario de Santiago de Compostela

Address:
City: Santiago de Compostela
Zip: 15706
Country: Spain

Status: Recruiting

Contact:
Last name: Estiban Mendez, Bsc

Phone: +34 663 609 134
Email: estiban.mendez.barrio@sergas.es

Facility:
Name: Hospital Universitario Virgen Macarena

Address:
City: Sevilla
Zip: 41009
Country: Spain

Status: Not yet recruiting

Contact:
Last name: María del Carmen Álamo, MD

Phone: +34 629 310 196 (611565)
Email: alamodelagala@gmail.com

Contact backup:
Last name: María Candón, SC

Phone: +34 629 310 196 (611565)
Email: mariacandon.oncomacarena@gmail.com

Facility:
Name: Hospital General Universitario Valencia

Address:
City: Valencia
Zip: 46014
Country: Spain

Status: Not yet recruiting

Contact:
Last name: Alfonso Berrocal, MD

Phone: +34 96 313 18 00

Phone ext: 437635
Email: berrocal.alf@gmail.com

Contact backup:
Last name: Iris Ramos

Phone: +34 96 313 18 00

Phone ext: 437635
Email: ramos_iri@gva.es

Facility:
Name: Dermatologische Klinik, USZ Flughafen Geschoss 7 - Klinische Forschung

Address:
City: Zuerich
Zip: 8058
Country: Switzerland

Status: Recruiting

Contact:
Last name: Reinhard Dummer, Prof. Dr. med

Phone: 0041 44 255 25 88
Email: reinhard.dummer@usz.ch

Facility:
Name: The Beatson West of Scotland Cancer Centre

Address:
City: Glasgow
Zip: G12 0YN
Country: United Kingdom

Status: Recruiting

Contact:
Last name: Ruth Orr

Phone: 00 44 (0) 141 301 7207
Email: ruth.orr@glasgow.ac.uk

Facility:
Name: Mount Vernon Cancer Centre East & North Herts NHS Trust

Address:
City: Northwood
Zip: HA6 2RN
Country: United Kingdom

Status: Recruiting

Contact:
Last name: Paul Nathan, Prof. Dr. med.

Phone: 0333 332 5470
Email: mvccresearch.enh-tr@nhs.net

Facility:
Name: The Clatterbridge Cancer Centre NHS Foundation Trust

Address:
City: Wirral
Zip: CH63 4JY
Country: United Kingdom

Status: Recruiting

Contact:
Last name: Joseph Sacco, Professor

Phone: 0151 556 5000
Email: joseph.sacco@nhs.net

Start date: October 31, 2023

Completion date: January 15, 2028

Lead sponsor:
Agency: IDEAYA Biosciences
Agency class: Industry

Source: IDEAYA Biosciences

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05987332

Login to your account

Did you forget your password?